FCBT
PTCT icon

First Citizens Bank & Trust’s PTC Therapeutics PTCT Stock Holding History

First Citizens Bank & Trust’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
12,595
+14
+0.1% +$1.01K 0.02% 319
2026
Q1 		$857K Buy
+12,581
New +$891K 0.02% 327

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

First Citizens Bank & Trust's PTCT Position: Q2 2026 in Review

First Citizens Bank & Trust increased its PTC Therapeutics (PTCT) stake by 0.11% in Q2 2026, buying an estimated $1.01K and bringing the position to 12,595 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #319.

First Citizens Bank & Trust first reported a position in PTCT in Q1 2026 and has held it in 2 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • First Citizens Bank & Trust held 12,595 shares of PTC Therapeutics worth $1.03M as of Q2 2026.
  • First Citizens Bank & Trust bought 14 PTC Therapeutics shares in Q2 2026, an estimated $1.01K.
  • PTC Therapeutics made up 0.02% of First Citizens Bank & Trust's portfolio in Q2 2026, its #319 holding.
  • First Citizens Bank & Trust first reported a position in PTC Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.